These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1912080)

  • 1. The taming of immunohistochemistry: the new era of quality control.
    Herman GE; Elfont EA
    Biotech Histochem; 1991; 66(4):194-9. PubMed ID: 1912080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance and standardization in immunohistochemistry. A proposal for the annual meeting of the Biological Stain Commission, June, 1991.
    Taylor CR
    Biotech Histochem; 1992 Mar; 67(2):110-7. PubMed ID: 1376149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary antisera before and after the expiration date. Comparative immunohistochemical observations and analysis of data sheets and labels].
    Vigliani R; Babache N
    Pathologica; 2002 Jun; 94(3):121-9. PubMed ID: 12108032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in immunohistochemistry.
    Johnson CW
    Toxicol Pathol; 1999; 27(2):246-8. PubMed ID: 10207991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of the Immunohistochemistry Steering Committee of the Biological Stain Commission. "Proposed format: package insert for immunohistochemistry products".
    Taylor CR
    Biotech Histochem; 1992 Nov; 67(6):323-38. PubMed ID: 1489835
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.
    Torlakovic EE; Cheung CC; D'Arrigo C; Dietel M; Francis GD; Gilks CB; Hall JA; Hornick JL; Ibrahim M; Marchetti A; Miller K; van Krieken JH; Nielsen S; Swanson PE; Vyberg M; Zhou X; Taylor CR;
    Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):79-85. PubMed ID: 28182587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission.
    Elias JM; Gown AM; Nakamura RM; Wilbur DC; Herman GE; Jaffe ES; Battifora H; Brigati DJ
    Am J Clin Pathol; 1989 Dec; 92(6):836-43. PubMed ID: 2480062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-2 testing in breast cancer using parallel tissue-based methods.
    Yaziji H; Goldstein LC; Barry TS; Werling R; Hwang H; Ellis GK; Gralow JR; Livingston RB; Gown AM
    JAMA; 2004 Apr; 291(16):1972-7. PubMed ID: 15113815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
    Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
    Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General Guidelines for Quality Assurance of Immunohistochemistry in a Mohs Lab.
    Kinas CG; Carroll BT
    Dermatol Surg; 2017 Apr; 43(4):507-511. PubMed ID: 28359076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance.
    Barnes DM; Millis RR; Beex LV; Thorpe SM; Leake RE
    Eur J Cancer; 1998 Oct; 34(11):1677-82. PubMed ID: 9893651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial preparations of colloidal gold-antibody complexes frequently contain free active antibody.
    Kramarcy NR; Sealock R
    J Histochem Cytochem; 1991 Jan; 39(1):37-9. PubMed ID: 1983872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of biological standards for the quality assurance of presumptive testing reagents.
    Laux DL
    Sci Justice; 2011 Sep; 51(3):143-5. PubMed ID: 21889112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control and quality assurance.
    Laessig RH; Ehrmeyer SS; Hassemer DJ
    Clin Lab Med; 1986 Jun; 6(2):317-27. PubMed ID: 3720254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralaboratory quality assurance of immunohistochemical procedures. Recommended practices for daily application.
    Rickert RR; Maliniak RM
    Arch Pathol Lab Med; 1989 Jun; 113(6):673-9. PubMed ID: 2471487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality requirements for critical assay reagents used in bioanalysis of therapeutic proteins: what bioanalysts should know about their reagents.
    Staack RF; Stracke JO; Stubenrauch K; Vogel R; Schleypen J; Papadimitriou A
    Bioanalysis; 2011 Mar; 3(5):523-34. PubMed ID: 21388265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To approve or not to approve? That is the question. Ethical concerns over the regulation of immunohistochemical stains.
    Taylor CR
    Arch Pathol Lab Med; 1994 Nov; 118(11):1086-92. PubMed ID: 7979892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pilot study on the quality management system of in-vitro diagnostic reagents].
    Liu X; Huang JH; Xu FL; Wang Z; Gu WK
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 May; 30(3):199-205. PubMed ID: 16929780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: More information please about commercial reagents.
    Newman PF
    J Clin Pathol; 1976 Aug; 29(8):762. PubMed ID: 956459
    [No Abstract]   [Full Text] [Related]  

  • 20. Assuring the quality of reagents for blood group serology.
    Bruce M
    Vox Sang; 1994; 67 Suppl 3():81-3. PubMed ID: 7975517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.